Clinical Trial Update: Immunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL) [NA]

View source ↗

Summary

Clinical trial update on immunotherapy for breast cancer-related upper extremity lymphedema (BCRL) has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Upper Extremity Lymphedema

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer, Upper Extremity Lymphedema | NA | Status: COMPLETED | Results posted: 2018-10-11